Mark Adams, Msc

Biography

Mark Adams joined Paragon in 2016 and brings over 25 years’ experience in the biotechnology industry in Program Management, Alliance Management and Business Development. In the course of his career, Mr. Adams has held positions with industry leaders and innovators in both the contract manufacturing and proprietary biological drug development sectors. Prior to joining Paragon, Mr. Adams was Vice President of Program Management at Cytovance Biologics where he established and grew the Program Management function and also managed a number of client development programs. Prior to Cytovance, Mr. Adams spent 4 years at Shire Human Genetic Therapies as Program Executive with responsibility for driving the development of a portfolio of pipeline products in various stages of clinical development for the treatment of human genetic diseases, and 7 years at Genzyme Transgenics Corp as Vice President of Commercial Development where he established the Program Management function and had responsibility for partnering the company’s proprietary transgenic technology for the production of biotherapeutics. Mr. Adams began his career at Pharmacia Biotech, Uppsala, Sweden where he held positions of increasing responsibility in both technical and commercial management functions supporting the growth of the company’s protein purification products business. Mr. Adams also held business development positions at PerSeptive Biosystems and Lonza Biologics. Mr. Adams holds a B.Sc.(Hons) and M.Sc. in biochemistry from University College Cork, Ireland. 

Research Interest

Biochemistry